Funding for this research was provided by:
Fundação de Amparo à Pesquisa do Estado de São Paulo (2013/10498-6 and 2013/00506-1, 2013/08531-5, 2008/57896-8)
Conselho Nacional de Desenvolvimento Científico e Tecnológico (573974/2008-0 and 442026/2014-5)
Text and Data Mining valid from 2019-03-13
First Online: 13 March 2019
Compliance with ethical standards
: Dr. Luis Augusto Rohde is supported by grants from CNPq and has been on the speakers’ bureau/advisory board and/or acted as a consultant for Eli-Lilly, Janssen-Cilag, Novartis and Shire in the last three years. The ADHD and Juvenile Bipolar Disorder Outpatient Programs he chaired received unrestricted educational and research support from the following pharmaceutical companies in the last three years: Eli-Lilly, Janssen-Cilag, Novartis, and Shire. He receives authorship royalties from Oxford Press and ArtMed. He has also received travel awards from Shire for his participation in the 2014 APA and 2015 WFADHD meetings. Dr. Rodrigo A. Bressan has been on the speakers’ bureau/advisory board of AstraZeneca, Bristol, Janssen and Lundbeck and has received research grants from Janssen, Eli Lilly, Lundbeck, Novartis, Roche, FAPESP, CNPq, CAPES, Fundação E.J. Safra and Fundação ABAHDS. He is a shareholder of Biomolecular Technology Ltd.